Scinovex
review Open AccessTop 1% cited

Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria

PLoS Genetics · 2018 · Vol. 14(12) · pp. e1007813–e1007813
Felix R. DayTugce KaraderiMichelle R. JonesCindy MeunChunyan HeAlex DrongPeter KraftNan LinHongyan HuangLinda BroerReedik MägiRicha SaxenaTriin LaiskMargrit UrbanekM. Geoffrey HayesGuðmar ÞorleifssonJuan Fernández‐TajesAnubha MahajanBenjamin H. MullinBronwyn StuckeyTimothy D. SpectorScott G. WilsonMark O. GoodarziLea K. DavisBarbara Obermayer‐PietschAndré G. UitterlindenVerneri AnttilaBenjamin M. NealeMarjo‐Riitta JärvelinBart C.J.M. FauserIrina KowalskaJenny A. VisserMarianne AndersenKen K. OngElisabet Stener‐VictorinDavid A. EhrmannRichard S. LegroAndres SalumetsMark I. McCarthyLaure Morin‐PapunenUnnur ÞorsteinsdóttirKāri StefánssonUnnur StyrkársdóttirJohn R. B. PerryAndrea DunaifJoop S.E. LavenSteve FranksCecilia M. LindgrenCorrine K. Welt

Abstract

Polycystic ovary syndrome (PCOS) is a disorder characterized by hyperandrogenism, ovulatory dysfunction and polycystic ovarian morphology. Affected women frequently have metabolic disturbances including insulin resistance and dysregulation of glucose homeostasis. PCOS is diagnosed with two different sets of diagnostic criteria, resulting in a phenotypic spectrum of PCOS cases. The genetic similarities between cases diagnosed based on the two criteria have been largely unknown. Previous studies in Chinese and European subjects have identified 16 loci associated with risk of PCOS. We report a fixed-effect, inverse-weighted-variance meta-analysis from 10,074 PCOS cases and 103,164 controls of European ancestry and characterisation of PCOS related traits. We identified 3 novel loci (near PLGRKT, ZBTB16 and MAPRE1), and provide replication of 11 previously reported loci. Only one locus differed significantly in its association by diagnostic criteria; otherwise the genetic architecture was similar between PCOS diagnosed by self-report and PCOS diagnosed by NIH or non-NIH Rotterdam criteria across common variants at 13 loci. Identified variants were associated with hyperandrogenism, gonadotropin regulation and testosterone levels in affected women. Linkage disequilibrium score regression analysis revealed genetic correlations with obesity, fasting insulin, type 2 diabetes, lipid levels and coronary artery disease, indicating shared genetic architecture between metabolic traits and PCOS. Mendelian randomization analyses suggested variants associated with body mass index, fasting insulin, menopause timing, depression and male-pattern balding play a causal role in PCOS. The data thus demonstrate 3 novel loci associated with PCOS and similar genetic architecture for all diagnostic criteria. The data also provide the first genetic evidence for a male phenotype for PCOS and a causal link to depression, a previously hypothesized comorbid disease. Thus, the genetics provide a comprehensive view of PCOS that encompasses multiple diagnostic criteria, gender, reproductive potential and mental health.

Ovarian function and disordersReproductive Biology and FertilityGenetic Associations and EpidemiologyPolycystic ovaryBiologyHyperandrogenismMendelian randomizationInsulin resistanceGenome-wide association studyLinkage disequilibriumGenetic architectureGeneticsType 2 diabetes

MeSH terms

FemaleHumansPhenotypePolycystic Ovary SyndromeCohort StudiesCase-Control StudiesGenetic Predisposition to DiseaseWhite PeopleAsian PeopleGenome-Wide Association Study

Funding

  • American Diabetes Association
  • Amgen
  • Pfizer
  • AstraZeneca
  • Sanofi
  • Harvard Catalyst
  • Li Ka Shing Foundation
  • Danone
  • Wellcome Trust
  • National Institute for Health and Care Research
  • European Commission
  • Raine Medical Research Foundation
  • Ettevõtluse Arendamise Sihtasutus
  • Tartu Ülikool
  • Servier
  • National Institutes of Health
  • Medical Research Council
  • European Regional Development Fund
  • NIHR Oxford Biomedical Research Centre
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of Child Health and Human Development
  • National Center for Research Resources
Citations
669
FWCI
42.61
field-weighted impact
References
77
Percentile
100%
vs. same field & year
Citations per year
Cited by
Obesity and polycystic ovary syndrome
Clinical Endocrinology · 2021 · 352 citations
Obesity and polycystic ovary syndrome
Clinical Endocrinology · 2006 · 619 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.